Shanghai Fosun Pharma, a China-based company, has announced that it will jointly invest $240m with Pramerica-Fosun China Opportunity Fund to purchase around 95.6% share of Israel-based Alma Lasers. Alma Lasers is a global medical and ...
Tags: Fosun Pharma, Alma Lasers